Efficacy and Safety of Neridronate (Nerixia®)to Treat Osteoporosis in Patients With TM and TI

NCT01140321 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Osteoporosis
Thalassemia Major
Thalassemia Intermedia

Interventions

DRUG: Neridronate

Sponsor

Ente Ospedaliero Ospedali Galliera

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]